Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Q16539 (MK14_HUMAN) Homo sapiens (Human)

Mitogen-activated protein kinase 14 UniProtKBInterProSTRINGInteractive Modelling

360 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5); 37 identical sequences

Available Structures

245 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of double-phosphorylated p38alpha with ATF2(83-102) Heteromer
P15336;
4-353
3FF;
Assess
Crystal structure of human p38alpha complexed with a MAPK docking peptide Heteromer
P52564;
4-353
Assess
Structure of dead kinase MAPK14 with bound the KIM domain of MKK6 Heteromer
P52564;
4-353
Assess
Structure of MAPK14 with bound the KIM domain of the Toxoplasma protein GRA24 Heteromer
B6KJB6;
4-353
Assess
Crystal Structure of the P38a-MAPKAP kinase 2 Heterodimer Heteromer
P49137;
4-352
Assess
Phosphorylated p38 and MAPKAPK2 complex with inhibitor Heteromer
P49137;
6-354
39G;
Assess
Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer Heteromer
P49137;
4-352
Assess
Structure of the MAPK p38alpha in complex with its activating MAP2K MKK6 Heteromer
P52564;
5-353
AP2;MG;
Assess
Human P38 MAP kinase in complex with RL48homo-2-mer4-352
R48;BOG;MES;
Assess
P38 ALPHA map kinase complexed with a benzothiazole based inhibitorhomo-2-mer4-352
P41;
Assess
P38ALPHA MAP KINASE BOUND TO CMPD 29monomer5-359
AAV;CL;
Assess
Human p38 MAP Kinase in Complex with 2-amino-phenylamino- dibenzosuberonemonomer1-353
2A8;
Assess
Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Pyrazolopyridazine Inh…monomer1-353
P66;
Assess
Joint NMR and X-ray refinement reveals the structure of a novel dibenzo[a,d]cycloheptenone inhibito…monomer2-354
Assess
Identification of novel p38 alpha MAP Kinase inhibitors using fragment-based lead generation.monomer4-355
LI2;GOL;
Assess
Human P38 MAP kinase in complex with RL45monomer4-355
1BU;BOG;
Assess
Identification of novel p38 alpha MAP Kinase inhibitors using fragment-based lead generation.monomer4-355
LI3;GOL;DMS;
Assess
Identification of novel p38 alpha MAP Kinase inhibitors using fragment-based lead generation.monomer4-355
WBT;
Assess
Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Pyrazolopyridinone Inh…monomer1-352
P37;
Assess
Crystal Structure of Human p38alpha complexed with a pyridinone compoundmonomer4-355
P36;I46;
Assess
p38 Kinase crystal structure in complex with small molecule inhibitormonomer4-355
L12;
Assess
p38 Kinase crystal structure in complex with small molecule inhibitormonomer4-355
L10;
Assess
p38 Kinase crystal structure in complex with small molecule inhibitormonomer4-355
3IP;
Assess
p38alpha bound to pyrazoloureamonomer2-353
1PP;
Assess
fragment based p38 inhibitorsmonomer4-355
L09;
Assess
Identification of novel p38 alpha MAP Kinase inhibitors using fragment-based lead generation.monomer4-355
LI4;
Assess
Structure of inactive MAPK14 with ordered Activation Loopmonomer1-352
SO4;
Assess
p38 Kinase crystal structure in complex with small molecule inhibitormonomer4-355
L11;
Assess
Structure of dead kinase MAPK14monomer1-352
Assess
P38 Complexed with a quinazoline inhibitormonomer1-352
P40;
Assess
Structural basis for kinase selectivity of three clinical p38alpha inhibitorsmonomer2-352
SB2;BOG;EDO;
Assess
mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-Amonomer4-354
BOG;
Assess
The W197A mutant of p38a MAP kinasemonomer3-353
Assess
Human p38 MAP kinase in complex with NP-F1 and RL87monomer4-354
IRG;0OK;
Assess
Human p38 MAP Kinase in Complex with 2-amino-phenylamino-benzophenonemonomer4-354
BOG;N3F;
Assess
Crystal Structure of p38 Alpha in Complex with a Selective Pyridazine Inhibitormonomer2-352
SO4;6NP;
Assess
Human p38 MAP kinase in complex with NP-F4 and RL87monomer4-354
IRG;0OM;
Assess
Crystal structure of P38 with triazolopyridinemonomer4-354
TZY;
Assess
Human p38 MAP kinase in complex with NP-F5 and RL87monomer4-354
IRG;0ON;
Assess
Human p38 MAP kinase in complex with NP-F6 and RL87monomer4-354
IRG;0OO;
Assess
fragment based p38 inhibitorsmonomer4-354
2CH;
Assess
Human p38 MAP kinase in complex with NP-F7 and RL87monomer4-354
IRG;0OP;
Assess
P38ALPHA MAP KINASE BOUND TO CMPD 22monomer5-355
QC0;
Assess
Triazolopyridine Inhibitors of p38monomer4-354
YIX;
Assess
Human p38 MAP kinase in complex with NP-F2 and RL87monomer4-354
NAR;IRG;
Assess
THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655monomer4-354
SB5;
Assess
THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025monomer4-354
SB4;
Assess
Human p38 MAP kinase in complex with NP-F3 and RL87monomer4-354
IRG;0OL;
Assess
THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580monomer4-354
SB2;
Assess
THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995monomer4-354
SB6;
Assess
Human p38 MAP kinase in complex with RL163monomer4-354
6RG;
Assess
Human p38 MAP Kinase in Complex with RL99monomer4-354
BOG;Z86;
Assess
Crystal structure of p38 alpha in complex with compound 75 (MCP33)monomer4-353
LB5;
Assess
The structure of p38 alpha in complex with a triazol inhibitormonomer4-353
P0F;
Assess
Crystal structure of p38 alpha in complex with compound 81 (MCP42)monomer4-353
EDO;LB8;
Assess
P38 kinase crystal structure in complex with R1487monomer3-352
3FN;
Assess
p38a bound with SR348monomer4-353
OE8;
Assess
Human p38 MAP kinase in complex with RL87monomer5-354
IRG;
Assess
Crystal structure of p38 alpha in complex with compound 77 (MCP41)monomer4-353
LBB;
Assess
Human p38 MAP Kinase in Complex with RL49monomer4-353
R49;BOG;GOL;
Assess
Human p38 MAP Kinase in Complex with RL182monomer4-353
BOG;DG7;
Assess
p38alpha in complex with pyrazolobenzothiazine inhibitor COXP4M12monomer4-353
BOG;9Y8;
Assess
Covalent Inhibitor 4a bound to the Lipid Pocket of p38alpha Mutant S251Cmonomer5-354
9O2;
Assess
Human P38 alpha Mitogen-Activated Kinase In Complex With SB239063monomer4-353
GG5;SB0;EDO;BME;
Assess
Crystal Structure of P38 Kinase in Complex with A Biaryl Amide Inhibitormonomer3-352
G6A;GOL;
Assess
Crystal Structure of P38 Kinase in Complex with A Biaryl Amide Inhibitormonomer4-353
19B;GOL;
Assess
Human p38 MAP kinase in complex with NP-F11 and RL87monomer5-354
IRG;0OQ;
Assess
Human p38 MAP Kinase in Complex with Dasatinibmonomer4-353
1N1;BOG;
Assess
Human p38 MAP Kinase in Complex with a Benzylpiperazin-Pyrrolmonomer4-353
PP0;BOG;
Assess
Structure of human p38aMAPK-arylpyridazinylpyridine fragment complex used in inhibitor discoverymonomer4-353
VVT;GG5;BME;
Assess
P38 ALPHA MUTANT C162S IN COMPLEX WITH CMPD2 [N-(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan…monomer4-353
8EN;
Assess
Crystal structure of p38alpha Y323Q active mutantmonomer4-353
BOG;
Assess
Crystal structure of P38alpha Y323R active mutantmonomer4-353
BOG;
Assess
Human p38 MAP Kinase in Complex with RL116monomer4-353
BOG;Z84;
Assess
Human P38 MAP Kinase in Complex with RL62monomer4-353
SS6;BOG;
Assess
Human p38 MAP Kinase in Complex with CP-547632monomer4-353
BOG;BFF;
Assess
Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9gmonomer5-354
8OH;
Assess
Human p38 MAP Kinase in Complex with an Indole Derivativemonomer4-353
BOG;DF3;
Assess
The structure of p38 alpha in complex with a dihydropyrido-pyrimidine inhibitormonomer4-353
094;
Assess
Human p38 MAP Kinase in Complex with RL98monomer4-353
Z87;BOG;
Assess
The structure of p38 alpha in complex with a triazol inhibitormonomer4-353
FTZ;
Assess
Human p38 MAP Kinase in Complex with RL113monomer4-353
Z85;BOG;
Assess
p38(alpha) MAP kinase with the activation loop of ERK2monomer4-352
BOG;EPE;
Assess
P38 kinase crystal structure in complex with 6-(2,4-Difluoro-phenoxy)-8-methyl-2-((S)-1-methyl-2-te…monomer4-352
FMK;
Assess
Phenylalanine pyrrolotriazine p38 alpha map kinase inhibitor compound 11Jmonomer4-352
287;
Assess
Human p38 MAP Kinase in Complex with RL40monomer4-352
BOG;G97;MES;
Assess
P38 kinase crystal structure in complex with RO5634monomer4-352
FL4;
Assess
Crystal structure of P38 in complex with 4-anilino quinoline inhibitormonomer4-352
ACT;GK1;GOL;
Assess
P38 kinase crystal structure in complex with 6-(2,4-difluoro-phenoxy)-2-isopropylamino-8-methyl-8h-…monomer4-352
FLY;
Assess
The structure of p38alpha in complex with a dihydroquinazolinonemonomer4-352
B45;
Assess
p38 kinase crystal structure in complex with small molecule inhibitormonomer4-352
CQ0;
Assess
mitogen activated protein kinase p38alpha (D176A) activating mutantmonomer5-353
BOG;
Assess
Human P38 alpha MAPK In Complex With a Novel and Selective Small Molecule Inhibitormonomer5-353
GG5;LM3;BME;PEG;
Assess
mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-Bmonomer4-352
BOG;
Assess
Crystal structure of P38 kinase in complex with a pyrrole-2-carboxamide inhibitormonomer4-352
1GK;GOL;
Assess
X-ray structure of p38alpha bound to TAK-715monomer4-352
T75;BOG;
Assess
Crystal structure of P38 alpha in complex with DP802monomer4-352
EDD;
Assess
P38 kinase crystal structure in complex with 6-(2,4-Difluoro-phenoxy)-8-methyl-2-((R)-1-methyl-2-te…monomer4-352
533;
Assess
P38 kinase crystal structure in complex with RO2530monomer4-352
530;
Assess
P38 kinase crystal structure in complex with 6-(2,4-difluoro-phenoxy)-2-((s)-2-methanesulfonyl-1-me…monomer4-352
891;
Assess
Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9lmonomer5-353
8ON;
Assess
Crystal structure of P38 kinase in complex with a biphenyl amide inhibitormonomer4-352
GK6;GOL;
Assess
Human p38 MAP Kinase in Complex with RL39monomer4-352
BOG;R39;
Assess
The structure of p38alpha in complex with an arylpyridazinonemonomer4-352
222;GOL;
Assess
P38 kinase crystal structure in complex with RO7125monomer4-352
FKN;
Assess
P38 kinase crystal structure in complex with RO9552monomer4-352
FKL;
Assess
Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[1,2-b]pyridazine-based p38 …monomer4-352
T75;
Assess
THE STRUCTURE OF P38ALPHA C162S MUTANTmonomer4-352
MG;
Assess
P38 kinase crystal structure in complex with 4-(5-Methyl-3-phenyl-isoxazol-4-yl)-pyrimidin-2-ylaminemonomer4-352
FMJ;
Assess
P38 kinase crystal structure in complex with RO6226monomer4-352
XI2;
Assess
P38 Alpha Map Kinase complexed with pyrrolotriazine inhibitor 7Vmonomer4-352
39P;
Assess
Structure of Inactive Human p38 MAP Kinase in Complex with a Thiazole-Ureamonomer4-352
HIZ;BOG;
Assess
triazolopyridine inhibitors of p38 kinasemonomer5-353
YIW;I46;
Assess
triazolopyridine inhibitors of p38 kinase.monomer5-353
YIS;I46;
Assess
X-ray structure of p38alpha bound to SCIO-469monomer4-352
469;BOG;
Assess
Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug candidatemonomer4-352
GG5;3GF;CL;
Assess
P38 Alpha kinase complexed with a 2-aminothiazol-5-yl-pyrimidine based inhibitormonomer5-353
3NW;
Assess
p38alpha MAP kinase bound to pyrazoloaminemonomer5-353
PQA;
Assess
Human p38 alpha MAPK in complex with a pyridazine based inhibitormonomer5-353
GG5;MWL;ZN;CL;BME;GOL;ACT;PEG;
Assess
Crystal structure of P38 in complex with biphenyl amide inhibitormonomer4-352
GK3;GOL;
Assess
Crystal structure of p38 in complex with a biphenylamide inhibitormonomer4-352
G11;SO4;GOL;
Assess
P38 kinase crystal structure in complex with RO6224monomer4-352
FML;
Assess
Crystal Structure of P38 Kinase in Complex with a biphenyl amide inhibitormonomer4-352
SO4;GK5;GOL;
Assess
The structure of p38 alpha in complex with a dihydroquinolinonemonomer4-352
358;GOL;
Assess
P38 kinase crystal structure in complex with pamapimodmonomer4-352
FLW;
Assess
Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Triazolopyridazinone i…monomer4-352
09J;
Assess
Human p38 MAP Kinase in Complex with a Dibenzosuberone Derivativemonomer5-353
FS8;BOG;
Assess
p38 kinase crystal structure in complex with small molecule inhibitormonomer4-352
I2O;
Assess
P38 kinase crystal structure in complex with RO4499monomer4-352
FI4;
Assess
P38ALPHA MAP KINASE BOUND TO CMPD 8monomer5-353
AQZ;
Assess
p38 kinase Crystal structure in complex with small molecule inhibitormonomer4-352
I39;
Assess
p38alpha MAP kinase bound to MPAQmonomer5-353
AQZ;
Assess
P38 Alpha kinase complexed with a 5-amino-pyrazole based inhibitormonomer4-352
OCG;
Assess
P38 kinase crystal structure in complex WITH 8-Methyl-6-phenoxy-2-(tetrahydro-pyran-4-ylamino)-8H-p…monomer4-352
FLZ;
Assess
Human P38 MAP Kinase in Complex with SB203580monomer4-352
SB2;BOG;
Assess
Human p38 MAP Kinase in Complex with Scios-469monomer4-352
BOG;469;
Assess
Human p38 MAP Kinase in Complex with RL24monomer4-352
R24;BOG;MES;
Assess
P38 alpha kinase complexed with a pyrazolo-triazine based inhibitormonomer4-352
NK0;
Assess
Crystal structure of p38alpha in complex with a photoswitchable 2-Azothiazol-based Inhibitor (compo…monomer5-353
BOG;GE5;
Assess
P38 kinase crystal structure in complex with 6-(2,4-Difluoro-phenoxy)-2-((R)-2-methanesulfonyl-1-me…monomer4-352
FLS;
Assess
Crystal structure of p38 kinase bound to pyrimido-pyridazinone inhibitormonomer5-353
CL;52P;
Assess
Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9cmonomer5-353
8OW;
Assess
P38 alpha kinase complexed with a pyrazolo-pyrimidine based inhibitormonomer4-352
N4D;
Assess
Human p38 MAP Kinase in Complex with an Imidazo-pyridinemonomer4-352
BOG;IPK;
Assess
Human p38alpha MAP Kinase in Complex with Dibenzosuberone Compound 2monomer5-353
78L;
Assess
THE COMPLEX STRUCTURE OF THE MAP KINASE P38/Compound 14bmonomer4-352
5JZ;
Assess
Crystal structure of P38 in complex with biphenyl amide inhibitormonomer4-352
GK4;GOL;
Assess
p38alpha in complex with pyrazolobenzothiazine inhibitor COXH11monomer5-353
9Y5;
Assess
Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with ETHYL 6-((5-(CYCLOPR…monomer4-352
1RA;
Assess
P38 in complex with T-3220137monomer4-352
MKP;
Assess
Human p38 MAP Kinase in Complex with RL51monomer4-352
L51;BOG;MES;
Assess
Crystal structure of p38alpha Y323T active mutantmonomer4-352
BOG;
Assess
Human p38 MAP Kinase in Complex with Skepinone-Lmonomer5-353
BOG;3FF;
Assess
P38 Alpha Map Kinase complexed with pyrrolotriazine inhibitor 7Kmonomer5-353
38P;
Assess
p38 kinase Crystal structure in complex with small molecule inhibitormonomer4-352
MIH;
Assess
P38 complex with a phthalazine inhibitormonomer4-352
A17;
Assess
mitogen activated protein kinase p38alpha (D176A+F327L) activating mutantmonomer5-352
BOG;
Assess
Human p38 MAP Kinase in Complex with RL166monomer5-352
BOG;Z83;
Assess
Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[1,2-b]pyridazine-based p38 …monomer5-352
AQY;
Assess
Crystal structure of Y323F inactive mutant of p38alpha MAP kinasemonomer5-352
BOG;
Assess
Human p38 MAP kinase in complex with NP-F10 and RL87monomer5-352
0SJ;IRG;
Assess
P38 Alpha Map Kinase inhibitor based on heterobicyclic scaffoldsmonomer5-352
LGF;
Assess
Crystal structure of p38alpha in complex with a reduced photoswitchable 2-Azothiazol-based Inhibito…monomer5-352
BOG;GXH;
Assess
Crystal structure of p38alpha in complex with a photoswitchable 2-Azoimidazol-based Inhibitor (comp…monomer5-352
BOG;GEW;
Assess
Crystal structure of human p38 alpha complexed with a pyrimidinone compoundmonomer5-352
29A;29B;
Assess
p38alpha bound to novel DGF-out compound PF-00215955monomer5-352
JZJ;I46;
Assess
P38 alpha complex with AR117045monomer5-352
I46;HYK;
Assess
MAPK14 with bound inhibitor SR-318monomer5-352
NA;LBE;GOL;
Assess
P38 Kinase Crystal Structure in complex with RO3201195monomer5-352
PQB;
Assess
Dibenzooxepinone inhibitor 12b in complex with p38 MAPKmonomer5-352
FJI;BOG;
Assess
Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridine-2-one based …monomer5-352
J8S;
Assess
Structure of human p38alpha with N-[4-methyl-3-(6-{[2-(1-methylpyrrolidin-2-yl)ethyl]amino}pyridine…monomer5-352
KQ7;ACT;
Assess
A Novel Lipid Binding Site in the p38 alpha MAP Kinasemonomer4-351
BOG;
Assess
P38ALPHA MAP KINASE BOUND TO CMPD 2monomer5-352
AA0;
Assess
P38 alpha complex with AR117046monomer5-352
I46;HYW;
Assess
Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9mmonomer4-351
8OK;
Assess
Human p38alpha MAPK in complex with imidazolyl pyridine inhibitor 11bmonomer5-352
BOG;1VI;
Assess
Structure of MAP kinase p38 in complex with a 1-o-tolyl-1,2,3-triazole-4-carboxamidemonomer5-352
337;
Assess
Crystal Structure of Human p38alpha complexed with PH-797804monomer5-352
I45;I46;PO2;
Assess
Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with 5-(2-CHLOROPHENYL)-N…monomer5-352
1M8;
Assess
P38alpha bound to novel DFG-out compound PF-00416121monomer5-352
F4C;I46;
Assess
Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Div…monomer5-352
BOG;B11;
Assess
Mutagenesis of p38 MAP Kinase eshtablishes key roles of Phe169 in function and structural dynamics …monomer5-352
BOG;
Assess
P38 kinase crystal structure in complex with RO3668monomer5-352
FKO;
Assess
Structure of p38a MAP kinase without BOGmonomer4-351
Assess
Covalent Inhibitor 4b bound to the Lipid Pocket of p38alpha Mutant S252Cmonomer5-352
9O5;
Assess
Human P38alpha MAPK in Complex with a Novel and Selective Small Molecule Inhibitormonomer5-352
GG5;LM4;ZN;ACT;BME;GOL;
Assess
HUMAN P38 MAP KINASE INHIBITOR COMPLEXmonomer5-352
D13;
Assess
Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9hmonomer5-352
8OT;
Assess
P38 kinase crystal structure in complex with RO6257monomer5-352
RO6;
Assess
Human P38 MAP Kinase in Complex with Inhibitor 1amonomer5-352
BOG;BI5;
Assess
Crystal Structure of Human p38alpha Complexed With a Triazolopyrimidine compoundmonomer5-352
L9G;
Assess
Conformational plasticity of p38 MAP kinase DFG-motif mutants in response to inhibitor bindingmonomer5-352
BMU;BOG;
Assess
p38a-PIA23 complexmonomer4-351
0O9;
Assess
Crystal structure of P38 alpha in complex with DP437monomer5-352
437;
Assess
Human P38 MAP kinase in complex with Sorafenibmonomer5-352
BAX;BOG;
Assess
Crystal structure of human p38alpha MAP kinasemonomer5-352
GG5;
Assess
P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4-AZAINDOLE INHIBITORmonomer5-352
FPH;
Assess
Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor bindingmonomer5-352
BMU;BOG;
Assess
Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor bindingmonomer5-352
SB2;BOG;
Assess
P38 kinase crystal structure in complex with 3-(2,6-Dichloro-phenyl)-7-[4-(2-diethylamino-ethoxy)-p…monomer5-352
FSS;
Assess
Mutagenesis of p38 MAP Kinase eshtablishes key roles of Phe169 in function and structural dynamics …monomer5-352
BOG;
Assess
Human p38 MAP kinase in complex with a Dibenzoxepinonemonomer5-352
BOG;F46;
Assess
Mutagenesis of p38 MAP kinase establishes key roles of Phe169 in function and structural dynamics a…monomer5-352
BOG;
Assess
P38 in complex with Sorafenibmonomer5-352
BAX;
Assess
Mutagenesis of p38 MAP kinase establishes key roles of Phe169 in function and structural dynamics a…monomer5-352
BOG;
Assess
Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with 2-(2-CHLOROPHENYL)-N…monomer5-352
1R9;
Assess
Crystal structure of phosphorylated P38 alpha in complex with DP802monomer5-352
EDD;
Assess
Mutagenesis of p38 MAP kinase establishes key roles of Phe169 in function and structural dynamics a…monomer5-352
BOG;
Assess
THE STRUCTURE OF P38ALPHAmonomer4-351
SO4;
Assess
Dibenzosuberone inhibitor 8e in complex with p38 MAPKmonomer5-352
HB9;BOG;
Assess
P38ALPHA MAP KINASE BOUND TO CMPD 33monomer5-352
NQB;
Assess
p38a-perifosine Complexmonomer4-351
0O8;
Assess
Crystal structure of P38 alpha in complex with DP1376monomer5-352
EDB;
Assess
Conformational plasticity of p38 MAP kinase DFG mutants in response to inhibitor bindingmonomer5-352
BMU;BOG;
Assess
Human p38 MAP Kinase in Complex with RL38monomer5-352
1AU;BOG;
Assess
Crystal structure of a N-Phenyl-N'-Naphthylurea analog in complex with p38 MAP kinasemonomer5-352
B10;
Assess
Human p38 MAP Kinase in Complex with a Benzamide Substituted Benzosuberonemonomer5-352
048;BOG;
Assess
Phenylalanine pyrrolotriazine p38 alpha map kinase inhibitor compound 11Bmonomer4-351
279;
Assess
Crystal structure of p38 MAP kinase in complex with a dihydroquinazolinone inhibitormonomer4-351
SO4;DQO;
Assess
P38 alpha map kinase complexed with BMS-640994monomer5-352
304;
Assess
Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9jmonomer6-353
BW1;B96;
Assess
Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridine-2-one based …monomer5-352
J9G;
Assess
P38 in complex with Imatinibmonomer5-352
STI;BOG;
Assess
The structure of p38 alpha in complex with a pyridinylimidazole inhibitormonomer4-351
SO4;084;
Assess
p38 MAP Kinase in Complex with Inhibitor 1monomer5-352
BMU;
Assess
p38-alpha complexed with Compound 10monomer5-352
3NE;
Assess
Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor bindingmonomer5-352
BMU;EDO;
Assess
Morpholino pyrrolotriazine P38 Alpha Map Kinase inhibitor compound 2monomer5-352
P39;
Assess
THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH 4-[3-METHYLSULFANYLANILINO]-6…monomer4-351
MSQ;
Assess
The crystal structure of p38a MAP kinase in complex with PIA24monomer4-351
0OA;
Assess
Human p38 MAP Kinase in Complex with BIRB 796monomer5-352
B96;
Assess
Conformational plasticity of p38 MAP kinase DFG mutants in response to inhibitor bindingmonomer5-352
SB2;
Assess
Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Pyrazolopyridinone Inh…monomer5-352
LHJ;
Assess
P38a MAP kinase DEF-pocket penta mutant (M194A, L195A, H228A, I229A, Y258A)monomer5-351
BOG;
Assess
Crystal Structure of Human p38alpha complexed with SD-0006monomer6-352
I47;I46;
Assess
Human p38 MAP Kinase in Complex with KM064monomer5-351
06F;BOG;
Assess
Human p38 MAP Kinase in Complex with Dibenzosuberone Compound 1monomer6-352
79Q;BOG;
Assess
Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor bindingmonomer5-351
BMU;BOG;EDO;
Assess
Crystal Structure of Human p38alpha complexed with a pyrimidopyridazinone compoundmonomer6-352
52P;I46;
Assess
STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATED PROTEIN KINASE P38 (P38 MAP KINASE) THE M…monomer5-351
Assess
Morpholino pyrrolotriazine P38 Alpha map kinase inhibitor compound 30monomer5-351
P38;
Assess
X-ray structure of p38alpha bound to VX-745monomer6-352
52P;BOG;
Assess
p38alpha bound to Ro3201195monomer5-351
PQB;
Assess
ERK2 MAP kinase with the activation loop of p38alphamonomer167-196
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1wbv.1.Amonomer0.884-354
LI3;100.00
Assess

4 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 21wbv.1.Amonomer0.874-354
LI3;96.11
Assess
Isoform 31wbv.1.Amonomer0.834-295
LI3;91.19
Assess
Isoform 45etc.1.Amonomer0.801-284
88.73
Assess
Isoform 51ouy.1.Amonomer0.854-255
094;99.61
Assess